Statistics Canada
www.statcan.gc.ca
Common menu bar links
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
Summary of key findings
The Manitoba Human Papillomavirus vaccine surveillance and evaluation system
Publication: Health Reports 2010:21(2) www.statcan.gc.ca/healthreports
Authors: Erich V. Kliewer, Alain A. Demers, Marc Brisson, Alberto Severini, Robert Lotocki, Brenda Elias, Gregory Hammond, George Wurtak and the Manitoba HPV Research Group
Data: Linked administrative databases, registries and questionnaire information
With the recent introduction of a human papillomavirus (HPV) vaccine in Canada, it is important to establish surveillance and evaluation programs that not only track the uptake of the vaccine, but also assess its safety and its impact.
Through partnerships with Manitoba Health, CancerCare Manitoba and the Public Health Agency of Canada’s National Microbiology Laboratory, and with access to extensive linkable data resources, Manitoba has developed such a surveillance and evaluation system.
Information arising from the system will provide data on many questions related to the vaccines’ uptake, impact and safety. Aspects of the Manitoba system could be implemented in other provinces that have similar databases.
For more information about this article, contact Erich V. Kliewer at Erich.Kliewer@cancercare.ca or 1-604-675-80000, ext. 7076.
